2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Europace

• Publication date

  2016-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/europace/euv411PMID 26585598
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Original InvestigationEditorial CommentEvolution of the ACC/AHA Clinical Practice Guidelines in Perspective: Guiding the Guidelines∗

  2015cited by this paper
• Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results.

  2015cited by this paper
• Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial

  2015cited by this paper
• ICD Shock, Not Ventricular Fibrillation, Causes Elevation of High Sensitive Troponin T after Defibrillation Threshold Testing—The Prospective, Randomized, Multicentre TropShock-Trial

  2015cited by this paper
• Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).

  2015influential reference
• Multicentre comparison Of shock efficacy using single-vs. Dual-coil lead systems and Anodal vs. cathodaL polarITY defibrillation in patients undergoing transvenous cardioverter-defibrillator implantation. The MODALITY study

  2015cited by this paper
• The association between biventricular pacing and cardiac resynchronization therapy-defibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodelling.

  2015cited by this paper
• Role of defibrillation threshold testing during implantable cardioverter-defibrillator placement: data from the Israeli ICD Registry.

  2014cited by this paper
• The Impact of Prolonged ICD Arrhythmia Detection

  2014cited by this paper
• Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRT.

  2014cited by this paper
• Reduction of unnecessary right ventricular pacing by managed ventricular pacing and search AV+ algorithms in pacemaker patients: 12-month follow-up results of a randomized study.

  2014cited by this paper
• Inappropriate Implant­ able Cardioverter­ Defibrillator Shocks

  2014cited by this paper
• The Benefit of a Second Burst Antitachycardia Sequence for Fast Ventricular Tachycardia in Patients with Implantable Cardioverter Defibrillators

  2014cited by this paper
• Mortality Reduction in Relation to Implantable Cardioverter Defibrillator Programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT)

  2014cited by this paper
• Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator.

  2014cited by this paper
• Is Defibrillation Testing Necessary for Implantable Transvenous Defibrillators?: Defibrillation Testing Should Not Be Routinely Performed at the Time of Implantable Cardioverter Defibrillator Implantation

  2014cited by this paper
• Decreased Delivery of Inappropriate Shocks Achieved by Remote Monitoring of ICD: A Substudy of the ECOST Trial

  2014cited by this paper
• The Epidemic of Inadequate Biventricular Pacing in Patients With Persistent or Permanent Atrial Fibrillation and Its Association With Mortality

  2014cited by this paper
• Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.

  2014cited by this paper
• Managed ventricular pacing compared with conventional dual-chamber pacing for elective replacement in chronically paced patients: results of the Prefer for Elective Replacement Managed Ventricular Pacing randomized study.

  2014cited by this paper
• Efficacy of Long Detection Interval ICD Settings in Secondary Prevention Population: Data from the Advance III Trial

  2014cited by this paper
• OUTCOME FOLLOWING ICD IMPLANTATION WITH VERSUS WITHOUT DEFIBRILLATION TESTING: PRELIMINARY RESULTS OF THE PROSPECTIVE RANDOMIZED TEST-NO TEST (TNT) PILOT STUDY

  2014cited by this paper
• Efficacy of Long Detection Interval Implantable Cardioverter-Defibrillator Settings in Secondary Prevention Population: Data From the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) Trial

  2014cited by this paper
• The Evolution and Future of ACC/AHA Clinical Practice Guidelines: A 30-Year Journey A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

  2014cited by this paper
• Impact of prolonged implantable cardioverter-defibrillator arrhythmia detection times on outcomes: a meta-analysis.

  2014cited by this paper
• Programming Implantable Cardioverter‐Defibrillators in Patients with Primary Prevention Indication to Prolong Time to First Shock: Results from the PROVIDE Study

  2014cited by this paper
• Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial

  2014cited by this paper
• Are dual-chamber implantable cardioverter-defibrillators really better than single-chamber ones? A systematic review and meta-analysis

  2014cited by this paper
• ESC Guidelines on cardiac pacing and cardiac resynchronization therapy

  2014cited by this paper
• Impact of Programming Strategies Aimed at Reducing Nonessential Implantable Cardioverter Defibrillator Therapies on Mortality: A Systematic Review and Meta-Analysis

  2014cited by this paper
• Cardiovascular mortality and chronotropic incompetence in systolic heart failure: the importance of a reappraisal of current cut‐off criteria

  2014cited by this paper
• ACR guidance document on MR safe practices: 2013

  2013cited by this paper
• Oral Abstract Session: Advances in ICD therapy and SCD prevention

  2013cited by this paper
• Patient, Physician, and Procedural Factors Influencing the Use of Defibrillation Testing during Initial Implantable Cardioverter Defibrillator Insertion: Findings from the NCDR®

  2013cited by this paper
• The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)

  2013cited by this paper
• Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.

  2013cited by this paper
• 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).

  2013cited by this paper
• The efficacy and safety of cardiac resynchronization therapy combined with implantable cardioverter defibrillator for heart failure: a meta-analysis of 5674 patients.

  2013cited by this paper
• Role of Defibrillation Threshold Testing in the Contemporary Defibrillator Patient Population

  2013cited by this paper
• The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011.

  2013cited by this paper
• Incidence and predictors of phantom shocks in implantable cardioverter defibrillator recipients

  2013cited by this paper
• Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial.

  2013cited by this paper
• Performance of Lead Integrity Alert to Assist in the Clinical Diagnosis of Implantable Cardioverter Defibrillator Lead Failures: Analysis of Different Implantable Cardioverter Defibrillator Leads

  2013influential reference
• Inappropriate Shocks in Patients with ICDs: Single Chamber versus Dual Chamber

  2013cited by this paper
• 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).

  2013cited by this paper
• The reverse mode switch algorithm: how well does it work?

  2013cited by this paper
• Impact of defibrillation testing on predicted ICD shock efficacy: implications for clinical practice.

  2013cited by this paper
• Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator

  2013cited by this paper
• Arrhythmia Management Devices

  2013cited by this paper
• Antitachycardia pacing for very fast ventricular tachycardia and low-energy shock for ventricular arrhythmias in patients with implantable defibrillators.

  2013cited by this paper
• Atrial fibrillation in patients with sick sinus syndrome: the association with PQ-interval and percentage of ventricular pacing.

  2012cited by this paper
• Effect of a Pacing Mode Preserving Spontaneous AV Conduction on Ventricular Pacing Burden and Atrial Arrhythmias

  2012cited by this paper
• Head‐To‐Head Comparison of Arrhythmia Discrimination Performance of Subcutaneous and Transvenous ICD Arrhythmia Detection Algorithms: The START Study

  2012cited by this paper
• HRS/ACCF expert consensus statement on pacemaker device and mode selection. Developed in partnership between the Heart Rhythm Society (HRS) and the American College of Cardiology Foundation (ACCF) and in collaboration with the Society of Thoracic Surgeons.

  2012cited by this paper
• HRS/ACCF expert consensus statement on pacemaker device and mode selection.

  2012cited by this paper
• A Randomized‐Controlled Pilot Study Comparing ICD Implantation with and Without Intraoperative Defibrillation Testing in Patients with Heart Failure and Severe Left Ventricular Dysfunction: A Substudy of the RAFT Trial

  2012cited by this paper
• Cardiac Dysfunction and Prolonged Hemodynamic Deterioration After Implantable Cardioverter-Defibrillator Shock in Patients With Systolic Heart Failure

  2012cited by this paper
• Noise, Artifact, and Oversensing Related Inappropriate ICD Shock Evaluation: ALTITUDE NOISE Study

  2012cited by this paper
• Recommendations for the programming of implantable cardioverter-defibrillators in New Zealand.

  2012cited by this paper
• Arrhythmia rate distribution and tachyarrhythmia therapy in an ICD population: results from the INTRINSIC RV trial.

  2012cited by this paper
• The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients.

  2012cited by this paper
• Prospective Randomized Trial of Dual Chamber vs. Single Chamber ICDs to Minimize Shocks in Optimally Programmed Devices

  2012cited by this paper
• Atrial Support Pacing in Heart Failure: Results from the Multicenter PEGASUS CRT Trial

  2012cited by this paper
• A randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods.

  2012cited by this paper
• A fully automatic, implantable cardioverter-defibrillator algorithm to prevent inappropriate detection of ventricular tachycardia or fibrillation due to T-wave oversensing in spontaneous rhythm.

  2012cited by this paper
• Left Ventricular Versus Simultaneous Biventricular Pacing in Patients With Heart Failure and a QRS Complex ≥120 Milliseconds

  2012cited by this paper
• Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial.

  2012cited by this paper
• A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial

  2012cited by this paper
• Reduction in inappropriate therapy and mortality through ICD programming.

  2012influential reference
• Clinical evaluation of defibrillation testing in an unselected population of 2,120 consecutive patients undergoing first implantable cardioverter-defibrillator implant.

  2012cited by this paper
• Single-chamber ICD, single-zone therapy in primary and secondary prevention patients: the simpler the better?

  2012cited by this paper
• Safety and efficacy of programming a high number of antitachycardia pacing attempts for fast ventricular tachycardia: a prospective study.

  2012cited by this paper
• Long-term follow-up on high-rate cut-off programming for implantable cardioverter defibrillators in primary prevention patients with left ventricular systolic dysfunction.

  2012cited by this paper
• Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality.

  2011cited by this paper
• Programming ICDs in the Modern Era beyond Out‐of‐the Box Settings

  2011cited by this paper
• Rate responsive pacing using cardiac resynchronization therapy in patients with chronotropic incompetence and chronic heart failure.

  2011cited by this paper
• Reduction of Right Ventricular Pacing with Advanced Atrioventricular Search Hysteresis: Results of the PREVENT Study

  2011cited by this paper
• Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival.

  2011cited by this paper
• Inappropriate Shocks in Patients With Fidelis® Lead Fractures: Impact of Remote Monitoring and the Lead Integrity Algorithm

  2011cited by this paper
• The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review.

  2011cited by this paper
• The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study.

  2011cited by this paper
• Combining Shock Reduction Strategies to Enhance ICD Therapy: A Role for Computer Modeling

  2011cited by this paper
• Preventing overdiagnosis of implantable cardioverter-defibrillator lead fractures using device diagnostics.

  2011cited by this paper
• Strategies to Reduce ICD Shocks: The Role of Supraventricular Tachycardia–Ventricular Tachycardia Discriminators

  2011cited by this paper
• Advances in Arrhythmia and Electrophysiology Posttraumatic Stress and the Implantable Cardioverter-Defibrillator Patient What the Electrophysiologist Needs to Know

  2011cited by this paper
• 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

  2011cited by this paper
• Advances in Arrhythmia and Electrophysiology Minimizing Inappropriate or “Unnecessary” Implantable Cardioverter-Defibrillator Shocks Appropriate Programming

  2011cited by this paper
• A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome.

  2011cited by this paper
• 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

  2011cited by this paper
• Left Ventricular Versus Simultaneous Biventricular Pacing in Patients With Heart Failure and a QRS Complex ≥120 Milliseconds

  2011cited by this paper
• Real World Evaluation of Dual‐Zone ICD and CRT‐D Programming Compared to Single‐Zone Programming: The ALTITUDE REDUCES Study

  2011cited by this paper
• Outcome of patients aged over 75 years who received a pacemaker to treat sinus node dysfunction.

  2011cited by this paper
• Atrial pacing or ventricular backup-only pacing in implantable cardioverter-defibrillator patients.

  2010cited by this paper
• BIVentricular versus right ventricular antitachycardia pacing to terminate ventricular tachyarrhythmias in patients receiving cardiac resynchronization therapy: the ADVANCE CRT-D Trial.

  2010cited by this paper
• Prospective multicenter randomized trial of fast ventricular tachycardia termination by prolonged versus conventional anti-tachyarrhythmia burst pacing in implantable cardioverter-defibrillator patients-Atp DeliVery for pAiNless ICD thErapy (ADVANCE-D) Trial results

  2010cited by this paper
• Programming Antitachycardia Pacing for Primary Prevention in Patients With Implantable Cardioverter Defibrillators: Results From the PROVE Trial

  2010cited by this paper
• Cardiac-resynchronization therapy for mild-to-moderate heart failure.

  2010cited by this paper
• The Relationship between Pacing Site and Induction or Termination of Sustained Monomorphic Ventricular Tachycardia by Antitachycardia Pacing

  2010cited by this paper
• Canadian Registry of ICD Implant Testing Procedures (CREDIT): Current Practice, Risks, and Costs of Intraoperative Defibrillation Testing

  2010cited by this paper
• Primary Results From the SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy (SMART-AV) Trial: A Randomized Trial Comparing Empirical, Echocardiography-Guided, and Algorithmic Atrioventricular Delay Programming in Cardiac Resynchron

  2010cited by this paper

• Incidence and Determinants of Implantable Cardioverter-Defibrillator Therapy With Loss of and Impaired Consciousness.

  2026cites this paper
• Incidence and Predictors of Appropriate Implantable Cardioverter-Defibrillator Therapy in Light Chain Cardiac Amyloidosis.

  2026cites this paper
• Pacemaker and ICD Programming Adherence With Evidence‐Based Recommendations

  2026cites this paper
• Adherence to Consensus-Based Implantable Cardioverter-Defibrillator Programming and Impact on Therapy Delivery in Clinical Practice: A National Cohort Study

  2026cites this paper
• The risk of failure of subcutaneous implantable cardioverter defibrillator therapy: from PRAETORIAN score to clinical practice

  2025cites this paper
• Alertas de arritmias ventriculares y supervivencia en pacientes con desfibriladores implantables bajo monitorización remota

  2025cites this paper
• Long-term low-voltage impedance measurements in subcutaneous implantable cardioverter-defibrillators

  2025cites this paper
• Contemporary Issues in Implantable Cardioverter-Defibrillators: Personalising Device Therapy.

  2025cites this paper
• Efficacy of Delivery Catheter for the Right Ventricular Septal Placement of a Defibrillator Lead

  2025cites this paper
• Impact of Statement-Concordant Implantable Cardioverter-Defibrillator Programming on Therapy Reduction in an Asian Cohort

  2025cites this paper
• Head-to-Head Comparison of Single- Versus Dual-Chamber ICD Discriminators for Tachyarrhythmia Detection: A Single-Manufacturer, Remote Monitoring-Based Bicentric Study

  2025cites this paper
• Reducing Unnecessary Implantable Cardioverter‐Defibrillator Therapy With ENHANCED Programming: Long‐Term Outcomes of the ENHANCED‐ICD Study

  2025cites this paper
• Cardiac resynchronization therapy optimization by targeting papillary muscle dyssynchrony: A case report

  2025cites this paper
• Veterans health administration national cardiac device surveillance program: Structured, centralized remote monitoring for cardiovascular implantable electronic devices to improve quality of care

  2025cites this paper
• Response to the Letter to the Editor “How to Manage Ventricular Arrhythmia Following Durable Left Ventricular Assist Device Implantation”

  2025cites this paper
• Exercise and Sports Participation in Patients with Cardiac Implantable Electronic Devices.

  2025cites this paper
• SGLT2i reduce arrhythmic events in heart failure patients with cardiac implantable electronic devices

  2025cites this paper
• Long term outcomes post-ICD in Chagas cardiomyopathy and non-ischemic cardiomyopathy: A comparative analysis.

  2025cites this paper
• Guías mexicanas 2024 para el diagnóstico y tratamiento de la miocardiopatía hipertrófica

  2025cites this paper
• Key influences of VDD (DX) ICD selection: results from a prospective, national survey

  2024cites this paper
• Impact of preventive substrate catheter ablation on implantable cardioverter-defibrillator interventions in patients with ischaemic cardiomyopathy and infarct-related coronary chronic total occlusion

  2024cites this paper
• Management of patients with an electrical storm or clustered ventricular arrhythmias: a clinical consensus statement of the European Heart Rhythm Association of the ESC—endorsed by the Asia-Pacific Heart Rhythm Society, Heart Rhythm Society, and Latin-American Heart Rhythm Society

  2024cites this paper
• Utility of routine follow‐up defibrillation safety margin testing in young patients with epicardial implantable cardioverter‐defibrillators

  2024cites this paper
• Current clinical practice versus remote monitoring recommendations for cardiovascular implantable electronic devices: A real-world analysis from a remote monitoring database

  2024cites this paper
• Arrhythmia Detection in Atrioventricular, Single-Lead, Floating Atrial Dipole ICD Systems Compared with Conventional Single- and Dual-Chamber Defibrillators

  2024cites this paper
• Failure of Ventricular Fibrillation Sensing During Subcutaneous Implantable Defibrillator Testing: A Twitchy Situation

  2024cites this paper
• Repeated antitachycardia pacing using the intrinsic algorithm in the ventricular fibrillation zone: Is it a risk or benefit?

  2024cites this paper
• Recent Advancements in Cardiac Implantable Devices for Pediatric Patients

  2024cites this paper
• Incidence and risk factors for first and recurrent ICD shock therapy in patients with an implantable cardioverter defibrillator

  2024cites this paper
• Effects of Irradiation During Computed Tomography Scanning on the Function of Implantable Cardioverter-defibrillators

  2024cites this paper
• Association between amount of biventricular pacing and heart failure status measured by a multisensor implantable defibrillator algorithm

  2024cites this paper
• Procedural Outcome and 1-Year Follow-Up of Young Patients Undergoing Implantable Cardioverter–Defibrillator Implantation—Insights from the German DEVICE I+II Registry

  2024cites this paper
• 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.

  2024cites this paper
• Desfibrilador subcutáneo. Primeros casos en el Instituto Nacional de Cardiología, incluyendo dos pacientes pediátricos

  2023cites this paper
• Kommentar zu den Leitlinien 2022 der ESC zu ventrikulären Arrhythmien und Prävention des plötzlichen Herztodes

  2023cites this paper
• A manual synchronous low energy shock impedance as a predictor of successful defibrillation testing during subcutaneous icd implantation

  2023influential citation
• Low rates of inappropriate shocks in contemporary real-world implantable cardioverter defibrillator patients: the CARAT observational study

  2023cites this paper
• RYR2-ryanodinopathies: from calcium overload to calcium deficiency

  2023cites this paper
• Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement

  2023cites this paper
• Design and rationale of the MODULAR ATP global clinical trial: A novel intercommunicative leadless pacing system and the subcutaneous implantable cardioverter-defibrillator

  2023cites this paper
• EHRA expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)

  2023cites this paper
• Defibrillation Threshold Testing for Right-sided Device Implants: A Review to Inform Shared Decision-making, in Association with the British Heart Rhythm Society

  2023cites this paper
• Subcutaneous cardioverter-defibrilator in EHRA/HRS/LAHRS/APHRS position papier in 2022

  2023cites this paper
• Ventricular tachyarrhythmia treatment and prevention by subthreshold stimulation with stretchable epicardial multichannel electrode array

  2023cites this paper
• Defibrillation effectiveness and safety of the shock waveform used in a contemporary wearable cardioverter defibrillator: Results from animal and human studies

  2023cites this paper
• ESC-Leitlinie 2022: Management ventrikulärer Arrhythmien in der klinischen Praxis

  2023cites this paper
• Implantable cardioverter-defibrillator in patients with inherited arrhythmia syndromes: A systematic review.

  2023cites this paper
• Management of Ventricular Arrhythmias Worldwide: Comparison of the Latest ESC, AHA/ACC/HRS, and CCS/CHRS Guidelines.

  2023cites this paper
• Diretriz Brasileira de Dispositivos Cardíacos Eletrônicos Implantáveis – 2023

  2023cites this paper
• Management of hemodynamically stable wide QRS complex tachycardia in patients with implantable cardioverter defibrillators

  2023cites this paper
• Performance of Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) in Chinese Population with Primary Prevention Indications: A Prospective Observational Cohort Study

  2023cites this paper
• Interference of Atrial Fibrillation with Implantable Cardioverter Defibrillator Therapy in Patients with Heart Failure and Reduced Ejection Fraction

  2023cites this paper
• Reducing inappropriate and unnecessary implantable cardioverter-defibrillator therapy: Is patient confirmation via a mobile application the solution?

  2023cites this paper
• Machine learning-derived cycle length variability metrics predict spontaneously terminating ventricular tachycardia in implantable cardioverter defibrillator recipients

  2023cites this paper
• Real-world use of a novel ventricular tachyarrhythmia detection algorithm: A case report

  2023cites this paper
• Etiologies, Mechanisms, Management, and Outcomes of Electrical Storm

  2023cites this paper
• Stereotactic Management of Arrhythmia - Radiosurgery in Treatment of Ventricular Tachycardia (SMART-VT). Results of a prospective safety trial.

  2023cites this paper
• Effectiveness of the Risk Stratification Proposed by the 2022 European Heart Rhythm Association Expert Consensus Statement on Arrhythmic Mitral Valve Prolapse.

  2023cites this paper
• Modern subcutaneous implantable defibrillator therapy in patients with cardiomyopathies and channelopathies: data from a large multicentre registry

  2023cites this paper
• Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity

  2023cites this paper
• Die Kardiologie

  2022cites this paper
• The “Defibrillation Testing, Why Not?” survey. Testing of subcutaneous and transvenous defibrillators in the Italian clinical practice

  2022cites this paper
• Propofol dose and efficacy of defibrillation testing during implantation of subcutaneous implantable cardioverter‐defibrillators: A retrospective, single center cohort study

  2022cites this paper
• Programming of implantable cardioverter defibrillators for primary prevention: outcomes at centers with high vs. low concordance with guidelines

  2022cites this paper
• Von der Extrasystole zur anhaltenden Kammertachykardie

  2022cites this paper
• 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.

  2022cites this paper
• Optimal Timing of Cardioverter-Defibrillator Implantation in Patients with Left Ventricular Dysfunction after Acute Myocardial Infarction

  2022cites this paper
• Arrhythmic Storm Due to ICD Atrial Lead Malfunction

  2022cites this paper
• Clinical Impact of Circulating Galectin-3 on Ventricular Arrhythmias and Heart Failure Hospitalization Independent of Prior Ventricular Arrhythmic Events in Patients with Implantable Cardioverter-defibrillators

  2022cites this paper
• Age-related differences and associated mid-term outcomes of subcutaneous implantable cardioverter defibrillators: a propensity-matched analysis from a multicenter European registry.

  2022cites this paper
• Importance of electromagnetic interactions between ICD and VAD devices - mechanistic assessment.

  2022cites this paper
• Anti-tachycardia Pacing: Mechanism, History and Contemporary Implementation

  2022cites this paper
• European Society of Cardiology quality indicators for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

  2022cites this paper
• Perplexing Results From the PRAETORIAN Trial: Revisiting the Debate About the Value of Antitachycardia Pacing.

  2022cites this paper
• Is 40 Joules Enough to Successfully Defibrillate With Subcutaneous Implantable Cardioverter Defibrillators?

  2021cites this paper
• Intermuscular Subcutaneous Implantable Cardioverter-Defibrillator Implantation Without Defibrillation Testing.

  2021cites this paper
• Novel Implantable Cardioverter Defibrillator Programming With High Rate Cut-Off, Long Detection Intervals and Multiple Anti-Tachycardia Pacing Reduces Mortality.

  2021cites this paper
• Advances in cardiac resynchronization and implantable cardioverter/defibrillator therapy: Medtronic Cobalt and Crome.

  2021cites this paper
• Comprehensive multicomponent cardiac rehabilitation in cardiac implantable electronic devices recipients: a consensus document from the European Association of Preventive Cardiology (EAPC; Secondary prevention and rehabilitation section) and European Heart Rhythm Association (EHRA).

  2021cites this paper
• EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS

  2021cites this paper
• Возможности и меры безопасности использования физиотерапии у пациентов с имплантированными антиаритмическими устройствами

  2021cites this paper
• Pregnancy in patients with implantable cardiac defibrillators

  2021cites this paper
• Acute shock efficacy of the subcutaneous implantable cardioverter‐defibrillator according to the implantation technique

  2021cites this paper
• The Defibrillation Conundrum: New Insights into the Mechanisms of Shock-Related Myocardial Injury Sustained from a Life-Saving Therapy

  2021cites this paper
• Guía ESC 2020 sobre cardiología del deporte y el ejercicio en pacientes con enfermedad cardiovascular

  2021cites this paper
• How to get the optimal defibrillation lead parameters using myocardial perfusion scintigraphy in patients with coronary artery disease

  2021cites this paper
• A novel risk model for predicting potentially life-threatening arrhythmias in non-ischemic dilated cardiomyopathy (DCM-SVA risk).

  2021cites this paper
• Safety of Omitting Defibrillation Efficacy Testing With Subcutaneous Defibrillators: a Propensity-Matched Case-Control Study.

  2021cites this paper
• Generic ICD programming and outcomes

  2021cites this paper
• Cardiac device troubleshooting in the intensive care unit: an educational review.

  2021cites this paper
• Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial

  2021cites this paper
• Effectiveness of Implantable Cardioverter-Defibrillators to Reduce Mortality in Patients With Long QT Syndrome.

  2021cites this paper
• Leitsymptom Dyspnoe, Leistungsschwäche

  2020cites this paper
• Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part 2: ventricular arrhythmias, channelopathies, and implantable defibrillators.

  2020cites this paper
• Arrhythmic event prediction in patients with heart failure and reduced ejection fraction

  2020cites this paper
• Current clinical practice of cardiac resynchronization therapy in Turkey: Reflections from Cardiac Resynchronization Therapy Survey-II

  2020cites this paper
• 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease.

  2020cites this paper
• How to minimize peri-procedural complications during subcutaneous defibrillator implant?

  2020cites this paper
• The implantable cardioverter–defibrillator

  2020cites this paper
• ERKRANKUNGEN DES HERZENS UND DES KREISLAUFS

  2020cites this paper